March 20, 2026 · Form 4 insider transaction
Hagen Brett R sold 1,915 shares of Kalaris Therapeutics, Inc. at $6.72 per share, a transaction worth $12.9K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 3 days after the transaction.
Due to an administrative error, the Reporting Person filed a Form 4 on March 27, 2025 reporting beneficial ownership of 1,925 shares, when in fact the amount of securities beneficially owned was 1,915. The number of shares beneficially owned by the Reporting Person following the transaction reported herein has been updated accordingly.